An Exploratory Study for the Association of Gut Microbiome with Efficacy of Immune Checkpoint Inhibitor in Patients with Hepatocellular Carcinoma.
Ying-Chun ShenPei-Chang LeeYu-Lun KuoWei-Kai WuChieh-Chang ChenChengh-Hau LeiChing-Ping YehChiun HsuChih-Hung HsuZhong-Zhe LinYu-Yun ShaoLi-Chun LuTsung-Hao LiuChien-Hung ChenMing-Shiang WuYi-Hsiang HuangAnn-Lii ChengPublished in: Journal of hepatocellular carcinoma (2021)
In this exploratory study, we failed to disclose any overt association of gut microbiome with the efficacy of ICI in patients with HCC. A larger prospective study is warranted for definite conclusion.
Keyphrases